Teva Pharmaceutical Industries Ltd (TEVA) — Capital Reinvestment Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Capital Reinvestment Ratio of 0.54x as of March 2026, meaning it reinvests 1% of its operating cash flow (ILA313.17 Million) in capital expenditures (ILA167.56 Million). See TEVA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Teva Pharmaceutical Industries Ltd Capital Reinvestment Ratio (1991–2025)
This chart tracks Teva Pharmaceutical Industries Ltd's Capital Reinvestment Ratio across 34 annual periods.
Annual Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year Capital Reinvestment Ratio for Teva Pharmaceutical Industries Ltd from 1991 to 2025. For live market cap and broader valuation context, see market cap of Teva Pharmaceutical Industries Ltd.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | ILA3.10 Billion | ILA542.32 Million | ▼ -56.2% |
| 2024 | 0.40x | ILA1.25 Billion | ILA498.00 Million | ▲ +3.9% |
| 2023 | 0.38x | ILA1.37 Billion | ILA526.00 Million | ▲ +11.6% |
| 2022 | 0.34x | ILA1.59 Billion | ILA548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | ILA798.00 Million | ILA562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | ILA1.22 Billion | ILA578.00 Million | ▲ +114.9% |
| 2019 | 0.22x | ILA538.00 Million | ILA119.00 Million | ▼ -16.9% |
| 2018 | 0.27x | ILA2.45 Billion | ILA651.00 Million | ▲ +6.8% |
| 2017 | 0.25x | ILA3.51 Billion | ILA874.00 Million | ▲ +44.5% |
| 2016 | 0.17x | ILA5.22 Billion | ILA901.00 Million | ▲ +23.8% |
| 2015 | 0.14x | ILA5.54 Billion | ILA772.00 Million | ▼ -23.1% |
| 2014 | 0.18x | ILA5.13 Billion | ILA929.00 Million | ▼ -43.1% |
| 2013 | 0.32x | ILA3.24 Billion | ILA1.03 Billion | ▲ +31.9% |
| 2012 | 0.24x | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA9.10 Million | ILA22.30 Million | — |